Jeff Lilly has been named director of technology for Nexstar’s Chicago owned station WGN.

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Neon's Tom Quinn says Netflix is actually their "biggest competitor" despite headlines suggesting it's A24. Quinn detailed how it was Netflix, and not fellow indie studio A24, that turned out to ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...

Eli Lilly (LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the production of key drug ingredients. Three of the four sites will produce ...

Neon is partnering with independent bookstores in New York City and Los Angeles to give away free limited edition prints of Sean Baker‘s Academy Award-nominated screenplay of Anora. The ...

In the run-up to the Academy Awards, Neon took a unique approach to scoring the season’s top prize for “Anora.” While other studios spent their money on tried-and-true strategies ...

Eli Lilly (LLY) announced the launch of 7.5 mg and 10 mg Zepbound single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program. Lilly also reduced the price of the 2.5 mg ...

16:22 EST Eli Lilly (LLY) files automatic mixed securities shelf See what stocks are receiving strong buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investmen ...

For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...